Peter Lönn
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 6
- TGF-β signaling in diseases 6
- Advanced biosensing and bioanalysis techniques 3
- Advanced Biosensing Techniques and Applications 2
-
- Biotin and Related Studies 1
- Co-authors
- Steven F. Dowdy (7 shared papers)Aristidis Moustakas (5 shared papers)Manuel Kaulich (3 shared papers)Markus Dahl (3 shared papers)Khirud Gogoi (2 shared papers)Alexander S. Hamil (2 shared papers)Xian-Shu Cui (2 shared papers)Carl‐Henrik Heldin (4 shared papers)
- Journals
- Nucleic Acids Research (3 papers)Journal of Controlled Release (2 papers)Trends in Biochemical Sciences (1 paper)Communications Biology (1 paper)Expert Opinion on Drug Delivery (1 paper)
- Partner nations
- SwedenUnited StatesAustria
In The Last Decade
Peter Lönn
21 papers receiving 2k citations
Peter Lönn's Hit Papers
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 305
- Biomaterials 333
- Molecular Medicine 155
- Molecular Biology 911
- Cell Biology 105
Countries citing papers authored by Peter Lönn
This map shows the geographic impact of Peter Lönn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lönn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lönn more than expected).
Fields of papers citing papers by Peter Lönn
This network shows the impact of papers produced by Peter Lönn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lönn. The network helps show where Peter Lönn may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lönn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors Hit paper breakdown → | 2014 | 686 |
| 2 | 2016 | 277 | |
| 3 | 2014 | 171 | |
| 4 | 2008 | 161 | |
| 5 | 2015 | 126 | |
| 6 | 2010 | 117 | |
| 7 | 2015 | 117 | |
| 8 | 2015 | 92 | |
| 9 | 2008 | 69 | |
| 10 | 2012 | 66 | |
| 11 | 2017 | 36 | |
| 12 | 2012 | 28 | |
| 13 | 2015 | 26 | |
| 14 | 2017 | 24 | |
| 15 | 2014 | 21 | |
| 16 | 2014 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2005 | 14 | |
| 19 | 2022 | 4 | |
| 20 | 2014 | 2 |
About Peter Lönn
Peter Lönn is a scholar working on Molecular Biology, Cell Biology, Biophysics, Pharmaceutical Science and Statistics, Probability and Uncertainty, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), TGF-β signaling in diseases (6 papers), Advanced biosensing and bioanalysis techniques (3 papers), Advanced Biosensing Techniques and Applications (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Academic Writing and Publishing (1 paper), Biotin and Related Studies (1 paper) and Nerve injury and regeneration (1 paper). The work is most often cited by research in Pharmaceutical Science (305 citations), Biomaterials (333 citations), Molecular Medicine (155 citations), Molecular Biology (911 citations) and Cell Biology (105 citations). Peter Lönn has collaborated with scholars based in Sweden, United States and Austria. Frequent co-authors include Steven F. Dowdy, Aristidis Moustakas, Manuel Kaulich, Markus Dahl, Khirud Gogoi, Alexander S. Hamil, Xian-Shu Cui, Carl‐Henrik Heldin, Erna Raja and Anita Morén. Their work appears in journals such as Nucleic Acids Research, Journal of Controlled Release, Trends in Biochemical Sciences, Communications Biology and Expert Opinion on Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.